Issie Kirby
Stock Analyst at Redburn Atlantic
(1.76)
# 3,137
Out of 4,749 analysts
6
Total ratings
33.33%
Success rate
7.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Issie Kirby
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Upgrades: Neutral | n/a | $91.09 | - | 1 | Oct 10, 2024 | |
| DXCM DexCom | Initiates: Neutral | $130 | $86.83 | +49.72% | 1 | May 30, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Buy | $60 | $37.06 | +61.90% | 1 | May 30, 2024 | |
| PODD Insulet | Initiates: Buy | $235 | $278.38 | -15.58% | 1 | May 30, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $125 | $96.55 | +29.47% | 2 | Mar 19, 2024 |
Alcon
Oct 10, 2024
Upgrades: Neutral
Price Target: n/a
Current: $91.09
Upside: -
DexCom
May 30, 2024
Initiates: Neutral
Price Target: $130
Current: $86.83
Upside: +49.72%
Tandem Diabetes Care
May 30, 2024
Initiates: Buy
Price Target: $60
Current: $37.06
Upside: +61.90%
Insulet
May 30, 2024
Initiates: Buy
Price Target: $235
Current: $278.38
Upside: -15.58%
The Cooper Companies
Mar 19, 2024
Upgrades: Buy
Price Target: $125
Current: $96.55
Upside: +29.47%